MedPage Today) — Despite the curative potential of CAR T-cell therapy in multiple myeloma and other hematologic cancers, only a fraction of eligible patients currently receive it. At the recent American Society of Clinical Oncology meeting, Jason…
Program Aims to Double CAR-T Access for Blood Cancers

Leave a Comment Leave a Comment